MiMedx Group, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
345.37 |
384.37 |
418.56 |
468.80 |
553.89 |
| Przychód Δ r/r |
0.00% |
11.29% |
8.90% |
12.00% |
18.15% |
| Przychód (min) |
341.38 |
379.92 |
407.10 |
463.38 |
547.48 |
| Przychód (max) |
350.62 |
390.20 |
432.00 |
475.92 |
562.30 |
| EBITDA (średnia) |
5.45 |
6.06 |
6.60 |
7.40 |
8.74 |
| EBIT (średnia) |
-1.36 |
-1.51 |
-1.64 |
-1.84 |
-2.17 |
| EBIT % |
-0.39% |
-0.39% |
-0.39% |
-0.39% |
-0.39% |
| Zysk netto (średni) |
43.68 |
39.05 |
47.52 |
57.88 |
134.14 |
| Zysk netto % |
12.65% |
10.16% |
11.35% |
12.35% |
24.22% |
| EPS (średnia) |
0.30 |
0.26 |
0.32 |
0.39 |
0.90 |
| Liczba analityków (Przychody) |
3 |
3 |
5 |
3 |
1 |
| Liczba analityków (EPS) |
2 |
2 |
3 |
3 |
1 |
| symbol |
MDXG |
MDXG |
MDXG |
MDXG |
MDXG |